Intellia Therapeutics tumbled after the gene-editing company suffered a significant legal setback on the same day it released early data on its leading drug candidate https://t.co/XKgivnDk0L— Bloomberg (@business) March 1, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


